Thermo Fisher Scientific Inc
NYSE:TMO

Watchlist Manager
Thermo Fisher Scientific Inc Logo
Thermo Fisher Scientific Inc
NYSE:TMO
Watchlist
Price: 513.26 USD -0.55% Market Closed
Market Cap: 196.3B USD
Have any thoughts about
Thermo Fisher Scientific Inc?
Write Note

Thermo Fisher Scientific Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Thermo Fisher Scientific Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Thermo Fisher Scientific Inc
NYSE:TMO
Retained Earnings
$51.4B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
18%
Danaher Corp
NYSE:DHR
Retained Earnings
$43.3B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
8%
West Pharmaceutical Services Inc
NYSE:WST
Retained Earnings
$3.9B
CAGR 3-Years
18%
CAGR 5-Years
21%
CAGR 10-Years
16%
Mettler-Toledo International Inc
NYSE:MTD
Retained Earnings
$8.1B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
14%
Agilent Technologies Inc
NYSE:A
Retained Earnings
$773m
CAGR 3-Years
105%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
IQVIA Holdings Inc
NYSE:IQV
Retained Earnings
$5.6B
CAGR 3-Years
43%
CAGR 5-Years
42%
CAGR 10-Years
N/A
No Stocks Found

Thermo Fisher Scientific Inc
Glance View

Market Cap
196.3B USD
Industry
Life Sciences Tools & Services

Thermo Fisher Scientific Inc. has positioned itself as a leading provider of scientific instruments, reagents, and consumables, playing a pivotal role in the life sciences, healthcare, and laboratory services sectors. Founded in 2006 from the merger of Thermo Electron and Fisher Scientific, the company's mission is to enable customers to make the world healthier, cleaner, and safer. With a diverse portfolio that includes everything from high-tech analytical equipment to diagnostic tests and laboratory management services, Thermo Fisher supports research and development in biotechnology, pharmaceuticals, and environmental applications. The company’s deep commitment to innovation is reflected in its substantial investment in R&D, which ensures that it remains at the cutting edge of scientific technology. For investors, Thermo Fisher represents a robust opportunity in a dynamic and growing market. With its extensive global reach, the company generated over $40 billion in revenue in its last fiscal year, benefiting from strong demand driven by trends in personalized medicine, genomics, and biotechnology advancements. A consistent track record of acquiring complementary companies has bolstered its product offerings and expanded its market presence, providing a competitive edge. As the world increasingly turns to science for solutions in health crises and environmental challenges, Thermo Fisher's value proposition remains strong, making it a compelling choice for investors seeking exposure to the evolving healthcare and life sciences landscape.

TMO Intrinsic Value
478.85 USD
Overvaluation 7%
Intrinsic Value
Price

See Also

What is Thermo Fisher Scientific Inc's Retained Earnings?
Retained Earnings
51.4B USD

Based on the financial report for Sep 28, 2024, Thermo Fisher Scientific Inc's Retained Earnings amounts to 51.4B USD.

What is Thermo Fisher Scientific Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
18%

Over the last year, the Retained Earnings growth was 12%. The average annual Retained Earnings growth rates for Thermo Fisher Scientific Inc have been 15% over the past three years , 19% over the past five years , and 18% over the past ten years .

Back to Top